Hemosiderin-laden macrophages are an independent factor correlated with pulmonary vascular resistance in idiopathic pulmonary fibrosis: A case control study

BMC Pulmonary Medicine

Volumn 17, Issue 1, 2017, Pages

  Fukihara, Jun ^a   Taniguchi, Hiroyuki ^a   Ando, Masahiko ^b   Kondoh, Yasuhiro ^a   Kimura, Tomoki ^a   Kataoka, Kensuke ^a   Furukawa, Taiki ^a   Johkoh, Takeshi ^c   Fukuoka, Junya ^d   Sakamoto, Koji ^e   Hasegawa, Yoshinori ^e  

^a TOSEI GENERAL HOSPITAL   (Japan)

^b NAGOYA UNIVERSITY HOSPITAL   (Japan)

^c Kinki Central Hospital of Mutual Association of Public School Teachers   (Japan)

^d NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

^e NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Bronchoalveolar lavage; Hemosiderin laden macrophages; Idiopathic pulmonary fibrosis; Mean pulmonary arterial pressure; Pulmonary vascular resistance; Right heart catheterization

Indexed keywords

HEMOSIDERIN;

ADULT; AGED; ARTICLE; BRONCHOALVEOLAR LAVAGE FLUID; CLINICAL EVALUATION; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FIBROSING ALVEOLITIS; HEART CATHETERIZATION; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG ARTERY PRESSURE; LUNG BIOPSY; LUNG HEMODYNAMICS; LUNG VASCULAR RESISTANCE; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; OXYGEN SATURATION; RETROSPECTIVE STUDY; ARTERIAL PRESSURE; CASE CONTROL STUDY; CHEMISTRY; CYTOLOGY; ECHOCARDIOGRAPHY; IDIOPATHIC PULMONARY FIBROSIS; JAPAN; LUNG; LUNG FUNCTION TEST; METABOLISM; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATHOLOGY; PATHOPHYSIOLOGY; SEVERITY OF ILLNESS INDEX; STATISTICAL MODEL; VASCULAR RESISTANCE; WALK TEST;

AGED; ARTERIAL PRESSURE; BRONCHOALVEOLAR LAVAGE FLUID; CARDIAC CATHETERIZATION; CASE-CONTROL STUDIES; ECHOCARDIOGRAPHY; FEMALE; HEMOSIDERIN; HUMANS; IDIOPATHIC PULMONARY FIBROSIS; JAPAN; LINEAR MODELS; LUNG; MACROPHAGES; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RESPIRATORY FUNCTION TESTS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; VASCULAR RESISTANCE; WALK TEST;

EID: 85011661524     PISSN: None     EISSN: 14712466     Source Type: Journal    
DOI: 10.1186/s12890-017-0376-8     Document Type: Article

References (29)

1. Golde DW, Drew WL, Klein HZ, Finley TN, Cline MJ. Occult pulmonary haemorrhage in leukaemia. Br Med J. 1975;2:166-8.
2. Kahn FW, Jones JM, England DM. Diagnosis of pulmonary hemorrhage in the immunocompromised host. Am Rev Respir Dis. 1987;136:155-60.
3. Kim KH, Maldonado F, Ryu JH, Eiken PW, Hartman TE, Bartholmai BJ, et al. Iron deposition and increased alveolar septal capillary density in nonfibrotic lung tissue are associated with pulmonary hypertension in idiopathic pulmonary fibrosis. Respir Res. 2010;11:37.
4. Puxeddu E, Comandini A, Cavalli F, Pezzuto G, D'Ambrosio C, Senis L, et al. Iron laden macrophages in idiopathic pulmonary fibrosis: The telltale of occult alveolar haemorrhage Pulm Pharmacol Ther. 2014;28:35-40.
5. Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK, et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med. 2011;183:788-824.
6. Rivera-Lebron BN, Forfia PR, Kreider M, Lee JC, Holmes JH, Kawut SM. Echocardiographic and hemodynamic predictors of mortality in idiopathic pulmonary fibrosis. Chest. 2013;144:564-70.
7. Corte TJ, Wort SJ, Gatzoulis MA, Macdonald P, Hansell DM, Wells AU. Pulmonary vascular resistance predicts early mortality in patients with diffuse fibrotic lung disease and suspected pulmonary hypertension. Thorax. 2009;64:883-8.
8. Nathan SD, Shlobin OA, Ahmad S, Urbanek S, Barnett SD. Pulmonary hypertension and pulmonary function testing in idiopathic pulmonary fibrosis. Chest. 2007;131:657-63.
9. Nathan SD, Shlobin OA, Barnett SD, Saggar R, Belperio JA, Ross DJ, et al. Right ventricular systolic pressure by echocardiography as a predictor of pulmonary hypertension in idiopathic pulmonary fibrosis. Respir Med. 2008;102:1305-10.
10. Zisman DA, Ross DJ, Belperio JA, Saggar R, Lynch 3rd JP, Ardehali A, et al. Prediction of pulmonary hypertension in idiopathic pulmonary fibrosis. Respir Med. 2007;101:2153-9.
11. Lettieri CJ, Nathan SD, Barnett SD, Ahmad S, Shorr AF. Prevalence and outcomes of pulmonary arterial hypertension in advanced idiopathic pulmonary fibrosis. Chest. 2006;129:746-52.
12. Modrykamien AM, Gudavalli R, McCarthy K, Parambil J. Echocardiography, 6-minute walk distance, and distance-saturation product as predictors of pulmonary arterial hypertension in idiopathic pulmonary fibrosis. Respir Care. 2010;55:584-8.
13. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31:315-24.
14. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982;25:1271-7.
15. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus [letter]. Arthritis Rheum. 1997;40:1725.
16. Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum. 1980;23:581-90.
17. Bohan A, Peter JB. Polymyositis and dermatomyositis (second of two parts). N Engl J Med. 1975;292:403-7.
18. Vitali C, Bombardieri S, Moutsopoulos HM, Balestrieri G, Bencivelli W, Bernstein RM, et al. Preliminary criteria for the classification of Sjögren's syndrome. Results of a prospective concerted action supported by the European Community. Arthritis Rheum. 1993;36:340-7.
19. Alarcon-Segovia D, Cardiel MH. Comparison between 3 diagnostic criteria for mixed connective tissue disease. Study of 593 patients. J Rheumatol. 1989;16:328-34.
20. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, et al. Standardisation of spirometry. Eur Respir J. 2005;26:319-38.
21. Macintyre N, Crapo RO, Viegi G, Johnson DC, van der Grinten CP, Brusasco V, et al. Standardisation of the single-breath determination of carbon monoxide uptake in the lung. Eur Respir J. 2005;26:720-35.
22. American Thoracic Society. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002;166:111-7.
23. Meyer KC, Raghu G, Baughman RP, Brown KK, Costabel U, du Bois RM, et al. An official American Thoracic Society clinical practice guideline: the clinical utility of bronchoalveolar lavage cellular analysis in interstitial lung disease. Am J Respir Crit Care Med. 2012;185:1004-14.
24. De Lassence A, Fleury-Feith AJ, Escudier E, Beaune J, Bernaudin JF, Cordonnier C. Alveolar hemorrhage, diagnostic criteria and results in 194 immunocompromised hosts. Am J Respir Crit Care Med. 1995;151:157-63.
25. Colombat M, Mal H, Groussard O, Capron F, Thabut G, Jebrak G, et al. Pulmonary vascular lesions in end-stage idiopathic pulmonary fibrosis: histopathologic study on lung explant specimens and correlations with pulmonary hemodynamics. Hum Pathol. 2007;38:60-5.
26. Ebina M, Shimizukawa M, Shibata N, Kimura Y, Suzuki T, Endo M, et al. Heterogeneous increase in CD34-positive alveolar capillaries in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2004;169:1203-8.
27. Renzoni EA, Walsh DA, Salmon M, Wells AU, Sestini P, Nicholson AG, et al. Interstitial vascularity in fibrosing alveolitis. Am J Respir Crit Care Med. 2003;167:438-43.
28. Magro CM, Waldman WJ, Knight DA, Allen JN, Nadasdy T, Frambach GE, et al. Idiopathic pulmonary fibrosis related to endothelial injury and antiendothelial cell antibodies. Hum Immunol. 2006;67:284-97.
29. Cottin V, Crestani B, Valeyre D, Wallaert B, Cadranel J, Dalphin JC, et al. Diagnosis and management of idiopathic pulmonary fibrosis: French practical guidelines. Eur Respir Rev. 2014;23:193-214.